According to TraceLink, biopharma companies can proactively monitor serialized operations, identify supply chain issues early, avoid costly delays and maintain timely product delivery to market. It could serve, TraceLink contends, as a first step in building a foundation for using more advanced technologies to predict and prevent critical business issues from occurring.
Serialized Product Intelligence is a fully automated, self-service analytics application, built on TraceLink’s Opus DNP, which the company says is the only such platform designed to support the development of multi-enterprise business applications for the pharma industry.
The post New application streamlines serialization techniques appeared first on Pharmaceutical Commerce.